Boomi Named a Leader for Ninth Consecutive Time in Gartner® Magic Quadrant™ for Integration Platform as a Service, Worldwide
Boomi TM, the intelligent connectivity and automation leader, today announced that Gartner has positioned Boomi as a Leader in its Magic Quadrant for Integration Platform as a Service (iPaaS), Worldwide for the ninth consecutive time. Gartner evaluated 16 iPaaS providers on their ability to execute and completeness of vision.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230130005154/en/
Boomi Named a Leader for Ninth Consecutive Time in Gartner® Magic Quadrant™ for Integration Platform as a Service, Worldwide (Graphic: Business Wire)
The iPaaS market is projected to reach $11 billion in revenue by 2026.1 Given the advanced capabilities and immense scale of iPaaS vendors, [iPaaS] has become the strategic integration platform of choice for hundreds of thousands of organizations around the world. In many cases, iPaaS has replaced previous generations of integration platform software such as application integration suites, data integration tools and B2B gateway software.2
“Boomi continues to have more customers than any other cloud integration provider,” said Steve Lucas, CEO at Boomi. “Our self-managing, self-learning, and self-scaling integrations run themselves autonomously – saving more time and money over the long term. We help organizations of all sizes and industries worldwide achieve better collaboration and data-sharing as their technology environments become more fragmented and complex. That’s why our mission of digital connectedness is more important than ever for business success.”
Trusted by customers across all industries globally, for its speed, ease-of-use, and lower total cost of ownership, the cloud-native, unified, low code, scalable, open, secure, and intelligent Boomi AtomSphere™ Platform helps organizations across all industries quickly and easily accelerate business outcomes. Boomi connects everyone to everything, anywhere, by providing end-to-end capabilities, including integration, master data management, API management, workflow automation, data quality governance, B2B/EDI network management, and data catalog and preparation.
Boomi recently announced significant updates to its platform and business, including:
Product Innovation
- Rapid API Creation – Single-click creation of an API from an integration flow to rapidly expose secure services to developers.
- Federal Risk Authorization Management Program (FedRAMP) Authorization – Boomi’s low-code workflow automation service, Boomi Flow, joined other Boomi platform services that have been FedRAMP authorized since 2019, including API Management, Integration, and Master Data Hub.
- IRAP Assessment – The Boomi AtomSphere Platform was independently assessed for cloud security against the Australian Government’s Information Security Manual (ISM) PROTECTED controls. Boomi’s security posture for storing, processing, and communicating information allows government agencies to purchase the Boomi platform without needing to complete their own independent assessments.
- B2B/EDI for the Automotive Industry – Support for the ODETTE standard for faster interoperability with a customer’s automotive supply chain.
Citizen Integrator/Business Technologist Enhancements
- Expanded Boomi Discover Catalog – More pre-built recipes to simplify integration.
- Simplified Visual Experience – New iconography, dynamic and responsive user engagement that provides the foundation for an engaging user experience.
- Accelerated Product Onboarding – Platform and Welcome Pages make it easy for the citizen integrator/business technologist to launch their journey.
Expanded Leadership and Global Reach
- Leadership Expansion – Boomi recently appointed Steve Lucas as Chief Executive Officer, a 3x CEO with more than 27 years of experience leading and operating some of the world’s most innovative, global enterprise software companies. Prior to spending three years growing iCIMS, Lucas held executive roles at Adobe, Marketo, SAP, and Salesforce, and brings specific expertise and experience in data management, platform as a service, and integration. As CEO of Marketo, Lucas implemented significant product expansion and platform growth, leading to Adobe’s $4.75 billion acquisition of the company.
- Global Growth – Boomi has also been continuing to scale rapidly, recently expanding its global footprint in Japan to address growing demand across Asia-Pacific.
As a category-leading, global software as a service (SaaS) company, Boomi touts a growing community of more than 100,000 members, and one of the largest arrays of global systems integrators (GSIs) in the iPaaS space. The company boasts a worldwide network of approximately 800 partners, including Accenture, Deloitte, SAP, and Snowflake; and works with the largest hyperscaler cloud service providers, including Amazon Web Services, Google and Microsoft, among others.
Recently included on the Deloitte Technology Fast 500™ and Inc. 5000 lists as one of America’s fastest growing and most innovative technology companies, Boomi has also won two International Stevie® Awards, for Company of the Year and Product Innovation; the Gold Globee® Award in the Platform as a Service (PaaS) category; the Merit Award for Technology in the Cloud Services category; the Stratus Award as a Global Leader in Cloud Computing 2022, and received the prestigious 5-star rating in the CRN Partner Program Guide, a definitive list of the most notable programs from industry-leading technology vendors that provide innovative products and flexible services through the IT channel. Boomi has also won numerous awards for being an employer of choice, including a recent listing as one of Inc. Magazine’s Best Workplaces.
To learn more about the iPaaS market and Boomi’s recognition, read the Gartner report: “Magic Quadrant for Integration Platform as a Service, Worldwide.”
Additional Resources
- Learn more in Boomi’s latest blog post from Ed Macosky, Chief Innovation Officer
- Explore the Boomiverse Community
- Follow Boomi on Twitter, LinkedIn, Facebook, and YouTube
Gartner Disclaimer:
Gartner, Magic Quadrant for Integration Platform as a Service, Worldwide, Keith Guttridge, Andrew Comes, Saikat Ray, January 24, 2023
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner and Magic Quadrant is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved. Note: Boomi was recognized as Dell Boomi from 2014 to 2019.
About Boomi
Boomi aims to make the world a better place by connecting everyone to everything, anywhere. The pioneer of cloud-based integration platform as a service (iPaaS), and now a category-leading, global software as a service (SaaS) company, Boomi touts the largest customer base among integration platform vendors and a worldwide network of approximately 800 partners – including Accenture, Capgemini, Deloitte, SAP, and Snowflake. Global organizations turn to Boomi’s award-winning platform to discover, manage, and orchestrate data, while connecting applications, processes, and people for better, faster outcomes. For more information, visit http://www.boomi.com.
© 2023 Boomi, LP. Boomi, the ‘B’ logo, Boomiverse, and AtomSphere are trademarks of Boomi, LP or its subsidiaries or affiliates. All rights reserved. Other names or marks may be the trademarks of their respective owners.
1 Forecast: Enterprise Infrastructure Software, Worldwide, 2020-2026, 4Q22 Update
2 Gartner, Magic Quadrant for Integration Platform as a Service, Worldwide, Keith Guttridge, Andrew Comes, Saikat Ray, January 24, 2023
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230130005154/en/
Contact information
Kristen Walker
Global Corporate Communications
kristenwalker@boomi.com
+1-415-613-8320
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 14:00:00 EET | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreement were not disclosed. “This new agreement builds upon our recent co-development collaboration with Acepodia, which has focused on the evaluation and selection
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 12:08:00 EET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 11:44:00 EET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 11:00:00 EET | Press release
Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE. “Insurance is an industry where the stakes of using AI are particularly high: the decisions can affect millions of people. Allianz and Anthropic both take that very seriously, and we look forward to working together to make insurance better for those w
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 08:00:00 EET | Press release
MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind, placebo-controlled study designed to confirm the promising efficacy signals and favorable safety profile previously observed in MH002’s Phase 2a studies. MH002, a rationally designed live microbial consortium, is the most advanced Live Biotherapeutic Product (LBP) of its kind, targeting disease-specific mechanisms through a synergistic combination of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
